The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[4-[(2,4-dioxothiazolidin-5-ylidene)methyl]phenoxy]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide ID: ALA4796336
PubChem CID: 162675911
Max Phase: Preclinical
Molecular Formula: C20H15N3O4S2
Molecular Weight: 425.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc2sc(NC(=O)COc3ccc(/C=C4\SC(=O)NC4=O)cc3)nc12
Standard InChI: InChI=1S/C20H15N3O4S2/c1-11-3-2-4-14-17(11)22-19(28-14)21-16(24)10-27-13-7-5-12(6-8-13)9-15-18(25)23-20(26)29-15/h2-9H,10H2,1H3,(H,21,22,24)(H,23,25,26)/b15-9-
Standard InChI Key: ODUMFGAXJVJOJL-DHDCSXOGSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
21.9348 -24.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9337 -25.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6458 -25.6782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3555 -25.2646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3527 -24.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6440 -24.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0630 -24.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7763 -24.4325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8639 -25.2484 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.6680 -25.4194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0781 -24.7060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5248 -24.0968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0074 -26.1688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6912 -23.2926 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2215 -25.6772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5100 -25.2640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7978 -25.6761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0863 -25.2628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7972 -26.4974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3775 -25.6696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6340 -25.3390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2921 -26.4858 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.4924 -26.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0883 -25.9467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2758 -25.9441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8664 -26.6478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2755 -27.3556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0866 -27.3547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8695 -25.2351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
10 13 2 0
12 14 2 0
2 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 2 0
21 24 1 0
23 22 1 0
22 20 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 425.49Molecular Weight (Monoisotopic): 425.0504AlogP: 3.95#Rotatable Bonds: 5Polar Surface Area: 97.39Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.19CX Basic pKa: ┄CX LogP: 3.94CX LogD: 2.62Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -2.21
References 1. Joshi H,Patil V,Tilekar K,Upadhyay N,Gota V,Ramaa CS. (2020) Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib., 30 (23.0): [PMID:32961322 ] [10.1016/j.bmcl.2020.127561 ]